Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

References

• Glassock RJ , Rule AD . The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int . 2012;82(3):270–277. doi:10.1038/ki.2012.65 22437416
   PubMed Web of Science ®Google Scholar
• Hosokawa K , Takata T , Sugihara T , et al. Ipragliflozin ameliorates endoplasmic reticulum stress and apoptosis through preventing ectopic lipid deposition in renal tubules. Int J Mol Sci . 2020;21(1):190. doi:10.3390/ijms21010190
   Web of Science ®Google Scholar
• Guebre-Egziabher F , Alix PM , Koppe L , et al. Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie . 2013;95(11):1971–1979. doi:10.1016/j.biochi.2013.07.017 23896376
   PubMed Web of Science ®Google Scholar
• Ni L , Yuan C , Chen G , Zhang C , Wu X . SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol . 2020;19(1). doi:10.1186/s12933-020-01071-y
   PubMed Web of Science ®Google Scholar
• Wilcox CS . Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors. Hypertension . 2020;75(4):894–901. doi:10.1161/HYPERTENSIONAHA.119.11684 32114848
   PubMed Web of Science ®Google Scholar
• Kashihara N , Kidokoro K , Kanda E . Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms. Curr Opin Nephrol Hypertens . 2020;29(1):112–118. doi:10.1097/MNH.0000000000000561 31725011
   PubMed Web of Science ®Google Scholar
• Chen H , Zhang L , Li X , et al. Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes. J Steroid Biochem Mol Biol . 2013;138:445–454. doi:10.1016/j.jsbmb.2013.08.013 23994141
   PubMed Web of Science ®Google Scholar
• Li Z , Lan D , Zhang H , Zhang H , Chen X , Sun J . Electroacupuncture mitigates skeletal muscular lipid metabolism disorder related to high-fat-diet induced insulin resistance through the AMPK/ACC signaling pathway. Evid Based Complement Alternat Med . 2018;2018:1–8.
   Web of Science ®Google Scholar
• Choi SR , Lim JH , Kim MY , et al. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy. Metabolism . 2018;85:348–360. doi:10.1016/j.metabol.2018.02.004 29462574
   PubMed Web of Science ®Google Scholar
• Zhang C , Deng J , Liu D , et al. Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway. Br J Pharmacol . 2018;175(22):4218–4228. doi:10.1111/bph.14482 30129056
   PubMed Web of Science ®Google Scholar
• Lu Y , Chang Y , Li T , et al. Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK/AKT/CREB signaling pathway in type 2 diabetic mice. Int J Biol Sci . 2020;16(3):529–542. doi:10.7150/ijbs.33007 32015688
   PubMed Web of Science ®Google Scholar
• Lee W , Chau Y , Ng H , et al. Empagliflozin protects HK-2 cells from high glucose-mediated injuries via a mitochondrial mechanism. Cells . 2019;8(9):1085. doi:10.3390/cells8091085
   Web of Science ®Google Scholar
• Yang W , Luo Y , Yang S , et al. Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease. Clin Sci . 2018;132(22):2407–2422. doi:10.1042/CS20180702
   Web of Science ®Google Scholar
• Han Q , Zhu H , Chen X , Liu Z . Non-genetic mechanisms of diabetic nephropathy. Front Med . 2017;11(3):319–332. doi:10.1007/s11684-017-0569-9 28871454
   PubMed Web of Science ®Google Scholar
• Leung WK , Gao L , Siu PM , Lai CW . Diabetic nephropathy and endothelial dysfunction: current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study. Life Sci . 2016;166:121–130. doi:10.1016/j.lfs.2016.10.015 27765534
   PubMed Web of Science ®Google Scholar
• Benetti E , Mastrocola R , Vitarelli G , et al. Empagliflozin protects against diet-induced NLRP-3 inflammasome activation and lipid accumulation. J Pharmacol Exp Ther . 2016;359(1):45–53. doi:10.1124/jpet.116.235069 27440421
   PubMed Web of Science ®Google Scholar
• Makrecka-Kuka M , Korzh S , Videja M , et al. Empagliflozin protects cardiac mitochondrial fatty acid metabolism in a mouse model of diet-induced lipid overload. Cardiovasc Drugs Ther . 2020;34(6):791–797. doi:10.1007/s10557-020-06989-9 32424653
   PubMed Web of Science ®Google Scholar
• Xu L , Nagata N , Chen G , et al. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet. BMJ Open Diabetes Res Care . 2019;7(1):e000783. doi:10.1136/bmjdrc-2019-000783
   PubMed Web of Science ®Google Scholar
• Nishimura R , Tanaka Y , Koiwai K , et al. Effect of empagliflozin on free fatty acids and ketone bodies in Japanese patients with type 2 diabetes mellitus: a randomized controlled trial. Adv Ther . 2019;36(10):2769–2782. doi:10.1007/s12325-019-01045-x 31444706
   PubMed Web of Science ®Google Scholar
• Hierro-Bujalance C , Infante-Garcia C , Del Marco A , et al. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes. Alzheimer’s Res Ther . 2020;12(1).
   Web of Science ®Google Scholar
• Masuda D , Yamashita S . Postprandial glucose and triglyceride increases along with the endothelial malfunction were attenuated by the administration of SGLT2 inhibitor, empagliflozin. J Atheroscler Thromb . 2020;27(7):637–638. doi:10.5551/jat.ED124 32009076
   PubMed Web of Science ®Google Scholar
• Park S , Farooq MA , Gaertner S , et al. Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat. Cardiovasc Diabetol . 2020;19(1). doi:10.1186/s12933-020-00997-7.
   Web of Science ®Google Scholar
• Madonna R , Doria V , Minnucci I , Pucci A , Pierdomenico DS , De Caterina R . Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes. J Cell Mol Med . 2020;24(21):12331–12340. doi:10.1111/jcmm.15699 32940423
   PubMed Web of Science ®Google Scholar
• Neeland IJ , McGuire DK , Chilton R , et al. Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus. Diabetes Vasc Dis Res . 2015;13(2):119–126. doi:10.1177/1479164115616901
   Web of Science ®Google Scholar
• Iwabu M , Yamauchi T , Okada-Iwabu M , et al. Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1. Nature . 2010;464(7293):1313–1319. doi:10.1038/nature08991 20357764
   PubMed Web of Science ®Google Scholar
• Kim Y , Lim JH , Kim MY , et al. The adiponectin receptor agonist adiporon ameliorates diabetic nephropathy in a model of type 2 diabetes. J Am Soc Nephrol . 2018;29(4):1108–1127. doi:10.1681/ASN.2017060627 29330340
   PubMed Web of Science ®Google Scholar
• Zha D , Wu X , Gao P . Adiponectin and its receptors in diabetic kidney disease: molecular mechanisms and clinical potential. Endocrinology . 2017;158(7):2022–2034. doi:10.1210/en.2016-1765 28402446
   PubMed Web of Science ®Google Scholar
• Grossini E , Farruggio S , Qoqaiche F , et al. Monomeric adiponectin modulates nitric oxide release and calcium movements in porcine aortic endothelial cells in normal/high glucose conditions. Life Sci . 2016;161:1–9. doi:10.1016/j.lfs.2016.07.010 27469459
   PubMed Web of Science ®Google Scholar
• Dahlhoff C , Worsch S , Sailer M , et al. Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Mol Metab . 2014;3(5):565–580. doi:10.1016/j.molmet.2014.04.010 25061561
   PubMed Web of Science ®Google Scholar
• Hong AR , Koo BK , Kim SW , Yi KH , Moon MK . Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in Korean patients with type 2 diabetes mellitus in real-world clinical practice. Diabetes Metab J . 2019;43(5):590. doi:10.4093/dmj.2018.0134 30877709
   PubMed Web of Science ®Google Scholar
• Petito-da-Silva TI , Souza-Mello V , Barbosa-da-Silva S . Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress. Mol Cell Endocrinol . 2019;498:110539. doi:10.1016/j.mce.2019.110539 31419466
   PubMed Web of Science ®Google Scholar
• Zhang Y , Deng Y , Tang K , et al. Berberine ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats via activation of SIRT3/AMPK/ACC pathway. Curr Med Sci . 2019;39(1):37–43. doi:10.1007/s11596-019-1997-3 30868489
   PubMed Web of Science ®Google Scholar
• Yuan E , Duan X , Xiang L , et al. Aged oolong tea reduces high-fat diet-induced fat accumulation and dyslipidemia by regulating the AMPK/ACC signaling pathway. Nutrients . 2018;10(2):187. doi:10.3390/nu10020187
   PubMed Web of Science ®Google Scholar
• Seo E , Kang H , Choi H , Choi W , Jun HS . Reactive oxygen species-induced changes in glucose and lipid metabolism contribute to the accumulation of cholesterol in the liver during aging. Aging Cell . 2019;18(2):e12895. doi:10.1111/acel.12895 30609251
   PubMed Web of Science ®Google Scholar
• Wang Y , Xue J , Li Y , Zhou X , Qiao S , Han D . Telmisartan protects against high glucose/high lipid-induced apoptosis and insulin secretion by reducing the oxidative and ER stress. Cell Biochem Funct . 2019;37(3):161–168. doi:10.1002/cbf.3383 30907023
   PubMed Web of Science ®Google Scholar
• Carracedo M , Artiach G , Arnardottir H , Back M . The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification. Semin Immunopathol . 2019;41(6):757–766. doi:10.1007/s00281-019-00767-y 31696250
   PubMed Web of Science ®Google Scholar
• Towler MC , Hardie DG . AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res . 2007;100(3):328–341. doi:10.1161/01.RES.0000256090.42690.05 17307971
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S , Chatterjee A , Kogan D , Patel D , Foster DA . 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells. Cell Cycle . 2015;14(20):3331–3339. doi:10.1080/15384101.2015.1087623 26323019
   PubMed Web of Science ®Google Scholar
• Mukherjee A , Wu J , Barbour S , Fang X . Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells. J Biol Chem . 2012;287(30):24990–25000. doi:10.1074/jbc.M112.340083 22665482
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S , Saqcena M , Chatterjee A , Garcia A , Frias MA , Foster DA . Reciprocal regulation of AMP-activated protein kinase and phospholipase D. J Biol Chem . 2015;290(11):6986–6993. doi:10.1074/jbc.M114.622571 25632961
   PubMed Web of Science ®Google Scholar